90
Growth Score in past quarter
pts
Heat Score 90in past quarter
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
4296406
LBx Bio develops an AI-driven molecular monitoring platform for oncology treatment response and recurrence detection.
About the Company
LBx Bio develops an AI-driven molecular monitoring platform for oncology care. The company focuses on detecting minimal residual disease and cancer recurrence using data from whole blood samples. Its multi-omic and software platform applies machine learning to analyze longitudinal molecular signals and track treatment response in near real time.
Clinical workflows begin with lung cancer minimal residual disease monitoring, targeting low tumor burden settings where detection is constrained by sampling frequency. LBx Bio positions its technology within precision oncology workflows, supporting clinicians and researchers who require rapid, repeated molecular readouts to inform therapy decisions.